Informations générales (source: ClinicalTrials.gov)
Covid-19 Pediatric Observatory (PANDOR)
Observational [Patient Registry]
Centre Hospitalier Intercommunal Creteil (Voir sur ClinicalTrials)
avril 2020
juin 2024
21 décembre 2024
In early December 2019, cases of pneumonia of unknown origin were reported in Wuhan,
Hubei Province in the People's Republic of China. The disease spreads rapidly and the
number of sick people is increasing. On January 3, 2020 a new virus of the coronavirus
family is identified in samples of bronchoalveolar lavage fluid from a patient in Wuhan
and subsequently confirmed as the cause of these pneumonias. On 7 January 2020, the World
Health Organization (WHO) designated it as the new coronavirus 2019 (i.e. 2019-nCoV). On
11 February 2020, the WHO designated the disease associated with 2019-nCoV as coronavirus
2019 disease (COVID-19). On 12 March, WHO announced that the COVID-19 outbreak is a
pandemic.
As of March 24, 2020, more than 375,000 cases of COVID-19 had been diagnosed with more
than 16,000 deaths attributed to this virus. (Ref WHO
https://www.who.int/emergencies/diseases/novel-coronavirus-2019 ).
In France, the number of cases rose from 105 cases at the end of February to 19615
confirmed cases on March 24. (Source Public Health France). Most of the cases are adults.
However, children are not completely spared and serious cases have been described. These
severe cases can be respiratory or extra-respiratory (e.g. myocarditis). We also know
that pediatric and adult cases differ in terms of clinical, biological and imaging
findings, particularly chest CT scans. However, the description of paediatric pictures,
especially severe forms and the involvement of children suffering from co-morbidities,
remains poorly reported. Finally, the risk factors for serious cases in children remain
largely unknown.
This observatory aim to describe the clinical phenotypes of hospitalized pediatric
patients with Covid19 in France, according to age groups. Moreover for a subgroup of
patients, informations regarding the long covid will be reported.
Etablissements
Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données | |||||
---|---|---|---|---|---|
CHI DE CRETEIL | Emilie GEORGET | 29/03/2024 01:30:01 | Contacter | ||
HOPITAL NOVO | ROBERT | 04/12/2024 13:04:51 | Contacter | ||
Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
CDS DENTAIRE PARIS HOTEL DE VILLE | François Angoulvant | Contact (sur clinicalTrials) | |||
CENTRE HOSPITALIER DE GONESSE | Maryssa Sarakbi | Contact (sur clinicalTrials) | |||
CENTRE HOSPITALIER SUD FRANCILIEN | Sebastien Rouget | Contact (sur clinicalTrials) | |||
CH VICTOR DUPOUY ARGENTEUIL | Philippe Bensaid, MD | Contact (sur clinicalTrials) | |||
CH DE MELUN SITE SANTEPOLE | Caroline Thach | Contact (sur clinicalTrials) | |||
CHI POISSY ST-GERMAIN | Philippe Blanc | Contact (sur clinicalTrials) | |||
CLINIQUE VILLENEUVE SAINT GEORGES | Aurélie Garraffo, MD | Contact (sur clinicalTrials) | |||
CMP DE NEUILLY SUR SEINE | Mariana Marin | Contact (sur clinicalTrials) | |||
IRM DE SAINT DENIS | Alexis Mandelcwajg, MD | Contact (sur clinicalTrials) | |||
USLD HOPITAL D ORGEMONT MEAUX | Olivier Vignaud | Contact (sur clinicalTrials) | |||
Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
Ch Armentieres - Armentières - France | Sophie Enchery | Contact (sur clinicalTrials) | |||
Ch Auxerre - Auxerre - France | Bertrand Soto | Contact (sur clinicalTrials) | |||
Ch Bretagne Atlantique - Vannes - France | Cécilia Marques, MD | Contact (sur clinicalTrials) | |||
CH de CHAMBERY - Chambéry - France | Charlène Dupré | Contact (sur clinicalTrials) | |||
Ch de Dax - Dax - France | Claude Chenel | Contact (sur clinicalTrials) | |||
CH de Montargis - Montargis - France | Richard Gruss | Contact (sur clinicalTrials) | |||
CH de MONTBRISON - Montbrison - France | Christine Roche | Contact (sur clinicalTrials) | |||
CH de ROMANS - Romans-sur-Isère - France | Patricia Guglielmino | Contact (sur clinicalTrials) | |||
Ch de Saint Malo - Saint-Malo - France | Jean-Marie Lepage | Contact (sur clinicalTrials) | |||
CH de TROYES - Troyes - France | Brigitte zimmerman | Contact (sur clinicalTrials) | |||
CH d'HYERES - Hyères - France | danielle Roybet | Contact (sur clinicalTrials) | |||
Ch Du Pays Du Mont Blanc - Sallanches - France | Emmanuelle Dessioux | Contact (sur clinicalTrials) | |||
CH Hautepierre - Strasbourg - France | Jeanne Bordet | Contact (sur clinicalTrials) | |||
Ch Hotel Dieu - Chartres - France | Rémi Kom | Contact (sur clinicalTrials) | |||
CH Jean Monnet - Épinal - France | Brigitte Auburtin | Contact (sur clinicalTrials) | |||
CH Louviers Val de Reuil - Elbeuf - France | Dana Dabbagh | Contact (sur clinicalTrials) | |||
CH RODEZ - Rodez - France | Bernard Caurier | Contact (sur clinicalTrials) | |||
Ch St Esprit - Agen - France | Marie Mizzi | Contact (sur clinicalTrials) | |||
Ch W. Morey - Chalon-sur-Saône - France | Sandrine Anne Martha | Contact (sur clinicalTrials) | |||
Chg Salon de Provence - Salon de Provence - France | Eric Moulène | Contact (sur clinicalTrials) | |||
CHGénéral du HAVRE - Le Havre - France | Belgaid Abdelmalek | Contact (sur clinicalTrials) | |||
Chr Orleans - Orléans - France | Françoise Monceaux | Contact (sur clinicalTrials) | |||
CHRU de Nancy - Nancy - France | Florent Girard | Contact (sur clinicalTrials) | |||
CHU Angers - Angers - France | Gerald Boussicault | Contact (sur clinicalTrials) | |||
CHU de BESANCON - Besançon - France | Raphaël Anxionnat | Contact (sur clinicalTrials) | |||
Chu Felix Guyon - Saint Denis - La Réunion - France | Benjamin Azemar | Contact (sur clinicalTrials) | |||
CHU Nimes Caremeau - Nîmes - France | Sophie Odorico, MD | Contact (sur clinicalTrials) | |||
Chu Rouen - Rouen - France | Nathalie Mestre | Contact (sur clinicalTrials) | |||
Chu St Etienne - Saint Etienne - France | Aymeric Cantais | Contact (sur clinicalTrials) | |||
CHU Toulouse-hôpital des Enfants - Toulouse - France | camille Brehin | Contact (sur clinicalTrials) | |||
Hopital Charles-Nicolle - Rouen - France | Didier Pinquier | Contact (sur clinicalTrials) | |||
Hopital D'Enfants Chu Dijon - Dijon - France | Frédéric Huet | Contact (sur clinicalTrials) | |||
Hopital Femme Enfant - Caen - France | Jacques Brouard | Contact (sur clinicalTrials) | |||
Hopital Femme Mere Enfant-Bron - Lyon - France | Manon Passard | Contact (sur clinicalTrials) | |||
Hopital Nord Enfants - Marseille - France | Philippe Minodier | Contact (sur clinicalTrials) | |||
Hopital Roger Salengro - Lille - Lille - France | François Dubos, MD | Contact (sur clinicalTrials) | |||
Hopital Saint Vincent de Paul - Lille - France | Valentine Hoeusler | Contact (sur clinicalTrials) | |||
Hopital Sainte Musse - Toulon - France | Paul Casha | Contact (sur clinicalTrials) | |||
Nantes - Hopital Mere Enfant - Nantes - France | Anne Drouard | Contact (sur clinicalTrials) | |||
Pringy - Ch D'Annecy - Annecy - France | Chantal Peigne | Contact (sur clinicalTrials) | |||
QUIMPER - CH de Cornouaille - Quimper - France | Camille Loeile | Contact (sur clinicalTrials) | |||
RANG du FLIERS - C.H.A.M. - RANG du FLIERS - France | Sylvie Louf | Contact (sur clinicalTrials) | |||
Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
CH Arpajon - Arpajon - France | Ekaterina KUTSIA | Contact (sur clinicalTrials) | |||
CH Bel Air - Thionville - France | Jean-Marc Schneider | Contact (sur clinicalTrials) | |||
CH d'ANGOULEME - Angoulème - France | Sylvie Roullaud | Contact (sur clinicalTrials) | |||
Ch de Longjumeau - Longjumeau - France | Sarah Ducrocq | Contact (sur clinicalTrials) | |||
Ch de Marne La Vallee - Jossigny - France | Nathalie Garrec | Contact (sur clinicalTrials) | |||
Ch General Aix En Provence - - Aix-en-Provence - France | Claire Charreton | Contact (sur clinicalTrials) | |||
CH GENERAL Henri Duffaut - Avignon - France | Charlotte Pons | Contact (sur clinicalTrials) | |||
Ch Le Chesnay - Versailles - France | Marie-Aliette Dommergue | Contact (sur clinicalTrials) | |||
CH Tarbes - Tarbes - France | Vanessa Latry, MD | Contact (sur clinicalTrials) | |||
Chru de Grenoble - La Tronche - France | Cécile Bost-Bru | Contact (sur clinicalTrials) | |||
CHU Estaing - Clermont-Ferrand - France | Isabelle Petit | Contact (sur clinicalTrials) | |||
Hopital Américain CHU REIMS - Reims - France | Elmerich Florence | Contact (sur clinicalTrials) | |||
Hopital Arnaud de Villeneuve - Montpellier - France | Lea Thevenet | Contact (sur clinicalTrials) | |||
Hopital de Mantes - Mantes-la-Jolie - France | Béatrice Pellegrino | Contact (sur clinicalTrials) | |||
Hôpital Gatien De Clocheville - Tours - France | Zoha Maakaroun-Vermesse | Contact (sur clinicalTrials) | |||
Hopital Jeanne de Flandre - Lille - France | Stéphane Leteurtre | Contact (sur clinicalTrials) | |||
Hopital Lenval - Nice - France | hervé Haas | Contact (sur clinicalTrials) | |||
Hopital Louis Mourrier - Colombes - France | Danekova | Contact (sur clinicalTrials) | |||
Hopital Louis Pasteur - Colmar - France | Didier Chognot | Contact (sur clinicalTrials) | |||
Hôpital Nord Franche-Comté - Trévenans - France | Nicoleta Ursulescu | Contact (sur clinicalTrials) | |||
Hopital St Jean Roussillon - Perpignan - France | Paulin Meslin | Contact (sur clinicalTrials) | |||
Lorient - Ch de Bretagne Sud - Lorient - France | Camille Le Stradic, MD | Contact (sur clinicalTrials) |
Critères
Tous
Inclusion Criteria:
- Children < 18 years old
- Admitted in French pediatric wards
- With a confirmed COVID-19 infection. ( on Nasal and pharyngeal swab specimens or
blood samples tested positive for 2019-nCoV nucleic acid using real-time
reverse-transcriptase polymerase-chain-reaction (RT- PCR) assay; or on typical chest
CT signs
- Children < 18 years old
- Admitted in French pediatric wards
- With a confirmed COVID-19 infection. ( on Nasal and pharyngeal swab specimens or
blood samples tested positive for 2019-nCoV nucleic acid using real-time
reverse-transcriptase polymerase-chain-reaction (RT- PCR) assay; or on typical chest
CT signs
- Expressed refusal to participate